Amoxicillin trihydrate
CHEMICAL NAME
(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino] -3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane -2-carboxylic acid trihydrate
FORMULA
C16H19N3O5S.3H2O
Potassium clavulanate
CHEMICAL NAME
Potassium (Z)-(2R,5R)-3-(2-hydroxyethylidene) -7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
FORMULA
C8H8NO5K
DESCRIPTION
White to slightly yellowish powder.
SPECIFICATIONS
The product meets Lek's specification.
Amoxicillin Trihydrate meets Ph. Eur. and USP requirements,
Potassium Clavulanate meets Ph. Eur. and USP requirements.
PHARMACOLOGICAL PROPERTIES
The combination of amoxicillin, a bactericidal penicillin antibiotics
with a broad spectrum of activity, and clavulanic acid, an
irreversible beta-lactamase inhibitor forming stable, inactive
complexes with the enzymes, thereby protecting amoxicillin from
degradation, possesses a broad spectrum of activity. The activity of
the combination is extended from microorganisms susceptible to
amoxicillin alone to also include amoxicillin-resistant beta-lactamase
producing organisms:
Amoxicillin and clavulanic acid have similar principal pharmacokinetic properties. The two substances are well absorbed from the gastrointestinal tract and readily diffuse into various body tissues and fluids.
USES
The combination of amoxicillin trihydrate and clavulanic acid potassium salt in the form
of tablets and/or suspension is indicated for the treatment of conditions listed below:
PRESENTATION
Double polyethylene bags inserted in multi-layer bags and drums.
Product protected by patent in a country are not offered or supplied to that country.
CORPORATION
Company overview | Lek Worldwide | Media Room | Employment Opportunities | Research and Development | Environmental Protection | Business Partners
HEALTH
Prescription Drugs | OTC Products | Active Pharmaceutical Ingredients
© LEK d.d. 1998-2008 / Legal notices